Prevalence of post-acute COVID-19 syndrome symptoms at different follow-up periods: a systematic review and meta-analysis
Mohamad Salim Alkodaymi, Osama Ali Omrani, Nader A Fawzy, Bader Abou Shaar, Raghed Almamlouk, Muhammad Riaz, Mustafa Obeidat, Yasin Obeidat, Dana Gerberi, Rand M Taha, Zakaria Kashour, Tarek Kashour, Elie F Berbari, Khaled Alkattan, Imad M Tleyjeh, Mohamad Salim Alkodaymi, Osama Ali Omrani, Nader A Fawzy, Bader Abou Shaar, Raghed Almamlouk, Muhammad Riaz, Mustafa Obeidat, Yasin Obeidat, Dana Gerberi, Rand M Taha, Zakaria Kashour, Tarek Kashour, Elie F Berbari, Khaled Alkattan, Imad M Tleyjeh
Abstract
Background: Post-acute coronavirus 2019 (COVID-19) syndrome is now recognized as a complex systemic disease that is associated with substantial morbidity.
Objectives: To estimate the prevalence of persistent symptoms and signs at least 12 weeks after acute COVID-19 at different follow-up periods.
Data sources: Searches were conducted up to October 2021 in Ovid Embase, Ovid Medline, and PubMed.
Study eligibility criteria, participants and interventions: Articles in English that reported the prevalence of persistent symptoms among individuals with confirmed severe acute respiratory syndrome coronavirus 2 infection and included at least 50 patients with a follow-up of at least 12 weeks after acute illness.
Methods: Random-effect meta-analysis was performed to produce a pooled prevalence for each symptom at four different follow-up time intervals. Between-study heterogeneity was evaluated using the I2 statistic and was explored via meta-regression, considering several a priori study-level variables. Risk of bias was assessed using the Joanna Briggs Institute tool and the Newcastle-Ottawa Scale for prevalence studies and comparative studies, respectively.
Results: After screening 3209 studies, a total of 63 studies were eligible, with a total COVID-19 population of 257 348. The most commonly reported symptoms were fatigue, dyspnea, sleep disorder, and difficulty concentrating (32%, 25%, 24%, and 22%, respectively, at 3- to <6-month follow-up); effort intolerance, fatigue, sleep disorder, and dyspnea (45%, 36%, 29%, and 25%, respectively, at 6- to <9-month follow-up); fatigue (37%) and dyspnea (21%) at 9 to <12 months; and fatigue, dyspnea, sleep disorder, and myalgia (41%, 31%, 30%, and 22%, respectively, at >12-month follow-up). There was substantial between-study heterogeneity for all reported symptom prevalences. Meta-regressions identified statistically significant effect modifiers: world region, male sex, diabetes mellitus, disease severity, and overall study quality score. Five of six studies including a comparator group consisting of COVID-19-negative cases observed significant adjusted associations between COVID-19 and several long-term symptoms.
Conclusions: This systematic review found that a large proportion of patients experience post-acute COVID-19 syndrome 3 to 12 months after recovery from the acute phase of COVID-19. However, available studies of post-acute COVID-19 syndrome are highly heterogeneous. Future studies need to have appropriate comparator groups, standardized symptom definitions and measurements, and longer follow-up.
Keywords: COVID-19; Coronavirus; PACS; Post-acute COVID-19 syndrome; SARS-CoV-2.
Copyright © 2022 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved.
Figures
References
- Sandler C.X., Wyller V.B.B., Moss-Morris R., Buchwald D., Crawley E., Hautvast J., et al. Long COVID and post-infective fatigue syndrome: a review. Open Forum Infect Dis. 2021;8:ofab440.
- Nalbandian A., Sehgal K., Gupta A., Madhavan M.V., McGroder C., Stevens J.S., et al. Post-acute COVID-19 syndrome. Nat Med. 2021;27:601–615.
- World Health Organization . 2021. A clinical case definition of post COVID-19 condition by a Delphi consensus. [cited 2021 Dec 19]. Available from:
- National Institute for Health and Care Excellence (UK) 2020. COVID-19 rapid guideline: managing the long-term effects of COVID-19. [cited 2021 Dec 19]. Available from:
- Lledó G.M., Sellares J., Brotons C., Sans M., Antón J.D., Blanco J., et al. Post-acute COVID-19 syndrome: a new tsunami requiring a universal case definition. Clin Microbiol Infect. 2022;28:315–318.
- Moher D., Shamseer L., Clarke M., Ghersi D., Liberati A., Petticrew M., et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement. Sys Rev. 2015;4:1.
- Shamseer L., Moher D., Clarke M., Ghersi D., Liberati A., Petticrew M., et al. Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation. BMJ. 2015;349:g7647.
- Sivan M., Taylor S. NICE guideline on long covid. BMJ. 2020;371:m4938.
- Munn Z., Moola S., Lisy K., Riitano D., Tufanaru C. Methodological guidance for systematic reviews of observational epidemiological studies reporting prevalence and cumulative incidence data. JBI Evid Implement. 2015;13:147–153.
- Guyatt G., Busse J. Methods commentary: risk of bias in cohort studies. [cited 2021 Dec 18]. Available from:
- Tleyjeh I.M., Kashour Z., AlDosary O., Riaz M., Tlayjeh H., Garbati M.A., et al. Cardiac toxicity of chloroquine or hydroxychloroquine in patients with COVID-19: a systematic review and meta-regression analysis. MCP:IQ&O. 2021;5:137–150.
- Barendregt J.J., Doi S.A., Lee Y.Y., Norman R.E., Vos T. Meta-analysis of prevalence. J Epidemiol Community Health. 2013;67:974.
- DerSimonian R., Laird N. Meta-analysis in clinical trials. Control Clin Trial. 1986;7:177–188.
- Higgins J.P.T., Thompson S.G., Deeks J.J., Altman D.G. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557–560.
- Deeks J., Higgins J.P., Altman D.G. Chapter 10: analysing data and undertaking meta-analyses. [cited 2021 Dec 18]. Available from:
- Viechtbauer W. Conducting meta-analyses in R with the metafor package. J Stat Softw. 2010;36:1–48.
- Elkan M., Dvir A., Zaidenstein R., Keller M., Kagansky D., Hochman C., et al. Patient-reported outcome measures after hospitalization during the COVID-19 pandemic: a survey among COVID-19 and Non-COVID-19 patients. Int J Gen Med. 2021;14:4829–4836.
- Zayet S., Zahra H., Royer P.-Y., Tipirdamaz C., Mercier J., Gendrin V., et al. Post-COVID-19 syndrome: nine months after SARS-CoV-2 infection in a cohort of 354 patients: data from the first wave of COVID-19 in Nord Franche-Comté Hospital, France. Microorganisms. 2021;9:1719.
- Mechi A., Al-Khalidi A., Al-Darraji R., Al-Dujaili M.N., Al-Buthabhak K., Alareedh M., et al. Long-term persistent symptoms of COVID-19 infection in patients with diabetes mellitus. Int J Diabetes Dev Ctries. 2021:1–4.
- Maestre-Muñiz M.M., Arias Á., Mata-Vázquez E., Martín-Toledano M., López-Larramona G., Ruiz-Chicote A.M., et al. Long-term outcomes of patients with coronavirus disease 2019 at one year after hospital discharge. J Clin Med. 2021;10:2945.
- Fernández-de-Las-Peñas C., Guijarro C., Plaza-Canteli S., Hernández-Barrera V., Torres-Macho J. Prevalence of post-COVID-19 cough one year after SARS-CoV-2 infection: a multicenter study. Lung. 2021;199:249–253.
- Lombardo M.D.M., Foppiani A., Peretti G.M., Mangiavini L., Battezzati A., Bertoli S., et al. Long-term coronavirus disease 2019 complications in inpatients and outpatients: a one-year follow-up cohort study. Open Forum Infect Dis. 2021;8:ofab384.
- Boscolo-Rizzo P., Guida F., Polesel J., Marcuzzo A.V., Capriotti V., D’Alessandro A., et al. Sequelae in adults at 12 months after mild-to-moderate coronavirus disease 2019 (COVID-19) Int Forum Allergy Rhinol. 2021;11:1685–1688.
- Huang L., Yao Q., Gu X., Wang Q., Ren L., Wang Y., et al. 1-year outcomes in hospital survivors with COVID-19: a longitudinal cohort study. Lancet. 2021;398:747–758.
- Clavario P., de Marzo V., Lotti R., Barbara C., Porcile A., Russo C., et al. Cardiopulmonary exercise testing in COVID-19 patients at 3 months follow-up. Int J Cardiol. 2021;340:113–118.
- Taquet M., Geddes J.R., Husain M., Luciano S., Harrison P.J. 6-month neurological and psychiatric outcomes in 236 379 survivors of COVID-19: a retrospective cohort study using electronic health records. Lancet Psychiatry. 2021;8:416–427.
- Menges D., Ballouz T., Anagnostopoulos A., Aschmann H.E., Domenghino A., Fehr J.S., et al. Burden of post-COVID-19 syndrome and implications for healthcare service planning: a population-based cohort study. PloS One. 2021;16
- Shoucri S.M., Purpura L., DeLaurentis C., Adan M.A., Theodore D.A., Irace A.L., et al. Characterising the long-term clinical outcomes of 1190 hospitalised patients with COVID-19 in New York City: a retrospective case series. BMJ Open. 2021;11
- Biadsee A., Dagan O., Ormianer Z., Kassem F., Masarwa S., Biadsee A. Eight-month follow-up of olfactory and gustatory dysfunctions in recovered COVID-19 patients. Am J Otolaryngol. 2021;42:103065.
- Wu Q., Zhong L., Li H., Guo J., Li Y., Hou X., et al. A follow-up study of lung function and chest computed tomography at 6 months after discharge in patients with coronavirus disease 2019. Can Respir J. 2021;2021:6692409.
- Shang Y.F., Liu T., Yu J.N., Xu X.R., Zahid K.R., Wei Y.C., et al. Half-year follow-up of patients recovering from severe COVID-19: analysis of symptoms and their risk factors. J Intern Med. 2021;290:444–450.
- Blomberg B., Mohn K.G.-I., Brokstad K.A., Zhou F., Linchausen D.W., Hansen B.-A., et al. Long COVID in a prospective cohort of home-isolated patients. Nat Med. 2021;27:1607–1613.
- Sigfrid L., Drake T.M., Pauley E., Jesudason E.C., Olliaro P., Lim W.S., et al. Long Covid in adults discharged from UK hospitals after Covid-19: a prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. Lancet Regional Health Europe. 2021;8:100186.
- Yin X., Xi X., Min X., Feng Z., Li B., Cai W., et al. Long-term chest CT follow-up in COVID-19 Survivors: 102–361 days after onset. Ann Transl Med. 2021;9:1231.
- Darcis G., Bouquegneau A., Maes N., Thys M., Henket M., Labye F., et al. Long-term clinical follow-up of patients suffering from moderate-to-severe COVID-19 infection: a monocentric prospective observational cohort study. Int J Infect Dis. 2021;109:209–216.
- Augustin M., Schommers P., Stecher M., Dewald F., Gieselmann L., Gruell H., et al. Post-COVID syndrome in non-hospitalised patients with COVID-19: a longitudinal prospective cohort study. Lancet Regional Health Europe. 2021;6:100122.
- Riestra-Ayora J., Yanes-Diaz J., Esteban-Sanchez J., Vaduva C., Molina-Quiros C., Larran-Jimenez A., et al. Long-term follow-up of olfactory and gustatory dysfunction in COVID-19: 6 months case-control study of health workers. Eur Arch Oto-Rhino-Laryngol. 2021;278:4831–4837.
- Aranda J., Oriol I., Martín M., Feria L., Vázquez N., Rhyman N., et al. Long-term impact of COVID-19 associated acute respiratory distress syndrome. J Infect. 2021;83:581–588.
- Caruso D., Guido G., Zerunian M., Polidori T., Lucertini E., Pucciarelli F., et al. Post-acute sequelae of COVID-19 pneumonia: six-month chest CT follow-up. Radiology. 2021;301:E396–E405.
- Simani L., Ramezani M., Darazam I.A., Sagharichi M., Aalipour M.A., Ghorbani F., et al. Prevalence and correlates of chronic fatigue syndrome and post-traumatic stress disorder after the outbreak of the COVID-19. J Neurovirol. 2021;27:154–159.
- Frontera J.A., Yang D., Lewis A., Patel P., Medicherla C., Arena V., et al. A prospective study of long-term outcomes among hospitalized COVID-19 patients with and without neurological complications. J Neurol Sci. 2021;426:117486.
- Kim Y., Kim S.-W., Chang H.-H., Kwon K.T., Bae S., Hwang S. Significance and associated factors of long-term sequelae in patients after acute COVID-19 infection in Korea. Infect Chemother. 2021;53:463–476.
- Han X., Fan Y., Alwalid O., Li N., Jia X., Yuan M., et al. Six-month follow-up chest CT findings after severe COVID-19 pneumonia. Radiology. 2021;299:E177–E186.
- Taboada M., Moreno E., Cariñena A., Rey T., Pita-Romero R., Leal S., et al. Quality of life, functional status, and persistent symptoms after intensive care of COVID-19 patients. Br J Anaesth. 2021;126:e110–e113.
- Huang C., Huang L., Wang Y., Li X., Ren L., Gu X., et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. 2021;397:220–232.
- Fernández-de-Las-Peñas C., Palacios-Ceña D., Gómez-Mayordomo V., Rodríuez-Jiménez J., Palacios-Ceña M., Velasco-Arribas M., et al. Long-term post-COVID symptoms and associated risk factors in previously hospitalized patients: a multicenter study. J Infect. 2021;83:237–279.
- Nguyen N.N., Hoang V.T., Lagier J.-C., Raoult D., Gautret P. Long-term persistence of olfactory and gustatory disorders in COVID-19 patients. Clin Microbiol Infect. 2021;27:931–932.
- Lindahl A., Aro M., Reijula J., Mäkelä M.J., Ollgren J., Puolanne M., et al. Women report more symptoms and impaired quality of life: a survey of Finnish COVID-19 survivors. Infect Dis. 2021:1–10.
- Qin W., Chen S., Zhang Y., Dong F., Zhang Z., Hu B., et al. Diffusion capacity abnormalities for carbon monoxide in patients with COVID-19 at 3-month follow-up. Eur Respir J. 2021;58:2003677.
- Schandl A., Hedman A., Lyngå P., Fathi Tachinabad S., Svefors J., Roël M., et al. Long-term consequences in critically ill COVID-19 patients: a prospective cohort study. Acta Anaesthesiol Scand. 2021;65:1285–1292.
- Mei Q., Wang F., Yang Y., Hu G., Guo S., Zhang Q., et al. Health issues and immunological assessment related to Wuhan’s COVID-19 survivors: a multicenter follow-up study. Front Med. 2021;8:617689.
- Froidure A., Mahsouli A., Liistro G., de Greef J., Belkhir L., Gérard L., et al. Integrative respiratory follow-up of severe COVID-19 reveals common functional and lung imaging sequelae. Respir Med. 2021;181:106383.
- González J., Benítez I.D., Carmona P., Santisteve S., Monge A., Moncusí-Moix A., et al. Pulmonary function and radiologic features in survivors of critical COVID-19: a 3-month prospective cohort. Chest. 2021;160:187–198.
- Qu G., Zhen Q., Wang W., Fan S., Wu Q., Zhang C., et al. Health-related quality of life of COVID-19 patients after discharge: a multicenter follow-up study. J Clin Nurs. 2021;30:1742–1750.
- Stavem K., Ghanima W., Olsen M.K., Gilboe H.M., Einvik G. Prevalence and determinants of fatigue after COVID-19 in non-hospitalized subjects: a population-based study. Int J Environ Res Public Health. 2021;18:2030.
- Parry A.H., Wani A.H., Shah N.N., Jehangir M. Medium-term chest computed tomography (CT) follow-up of COVID-19 pneumonia patients after recovery to assess the rate of resolution and determine the potential predictors of persistent lung changes. Egypt J Radiol Nucl Me. 2021;52:55.
- Mumoli N., Bonaventura A., Colombo A., Vecchié A., Cei M., Vitale J., et al. Lung function and symptoms in post-COVID-19 patients: a single-center experience. Mayo Clin Proc Innov Qual Outcome. 2021;5:907–915.
- Parente-Arias P., Barreira-Fernandez P., Quintana-Sanjuas A., Patiño-Castiñeira B. Recovery rate and factors associated with smell and taste disruption in patients with coronavirus disease 2019. Am J Otolaryngol. 2021;42:102648.
- Mattioli F., Stampatori C., Righetti F., Sala E., Tomasi C., de Palma G. Neurological and cognitive sequelae of Covid-19: a four month follow-up. J Neurol. 2021;268:4422–4428.
- Suárez-Robles M., Iguaran-Bermúdez M.D.R., García-Klepizg J.L., Lorenzo-Villalba N., Méndez-Bailón M. Ninety days post-hospitalization evaluation of residual COVID-19 symptoms through a phone call check list. Pan Afr Med. 2020;37:289.
- Jacobson K.B., Rao M., Bonilla H., Subramanian A., Hack I., Madrigal M., et al. Patients with uncomplicated coronavirus disease 2019 (COVID-19) have long-term persistent symptoms and functional impairment similar to patients with severe COVID-19: a cautionary tale during a global pandemic. Clin Infect Dis. 2021;73:e826–e829.
- Søraas A., Kalleberg K.T., Dahl J.A., Søraas C.L., Myklebust T.Å., Axelsen E., et al. Persisting symptoms three to eight months after non-hospitalized COVID-19, a prospective cohort study. PloS One. 2021;16
- Noel-Savina E., Viatgé T., Faviez G., Lepage B., Mhanna L.T., Pontier S., et al. Severe SARS-CoV-2 pneumonia: clinical, functional and imaging outcomes at 4 months. Respir Med Res. 2021;80:100822.
- González-Hermosillo J.A., Martínez-López J.P., Carrillo-Lampón S.A., Ruiz-Ojeda D., Herrera-Ramírez S., Amezcua-Guerra L.M., et al. Post-acute COVID-19 symptoms, a potential link with myalgic encephalomyelitis/chronic fatigue syndrome: a 6-month survey in a Mexican cohort. Brain Sci. 2021;11:760.
- Skala M., Svoboda M., Kopecky M., Kocova E., Hyrsl M., Homolac M., et al. Heterogeneity of post-COVID impairment: interim analysis of a prospective study from Czechia. Virol J. 2021;18:73.
- Seeßle J., Waterboer T., Hippchen T., Simon J., Kirchner M., Lim A., et al. Persistent symptoms in adult patients one year after COVID-19: a prospective cohort study. Clin Infect Dis. 2021 ciab611.
- Wallis T.J.M., Heiden E., Horno J., Welham B., Burke H., Freeman A., et al. Risk factors for persistent abnormality on chest radiographs at 12-weeks post hospitalisation with PCR confirmed COVID-19. Respir Res. 2021;22:157.
- Sathyamurthy P., Madhavan S., Pandurangan V. Prevalence, pattern and functional outcome of post COVID-19 syndrome in older adults. Cureus. 2021;13
- Motiejunaite J., Balagny P., Arnoult F., Mangin L., Bancal C., Vidal-Petiot E., et al. Hyperventilation as one of the mechanisms of persistent dyspnoea in SARS-CoV-2 survivors. Eur Respir J. 2021;58:2101578.
- Munker D., Veit T., Barton J., Mertsch P., Mümmler C., Osterman A., et al. Pulmonary function impairment of asymptomatic and persistently symptomatic patients 4 months after COVID-19 according to disease severity. Infection. 2021:1–12.
- Liang L., Yang B., Jiang N., Fu W., He X., Zhou Y., et al. Three-month follow-up study of survivors of coronavirus disease 2019 after discharge. J Korean Med Sci. 2020;35:e418.
- Boari G.E.M., Bonetti S., Braglia-Orlandini F., Chiarini G., Faustini C., Bianco G., et al. Short-term consequences of SARS-CoV-2-related pneumonia: a follow up study. High Blood Press Cardiovasc Prev. 2021;28:373–381.
- Wong A.W., Shah A.S., Johnston J.C., Carlsten C., Ryerson C.J. Patient-reported outcome measures after COVID-19: a prospective cohort study. Eur Respir J. 2020;56:2003276.
- Garrigues E., Janvier P., Kherabi Y., le Bot A., Hamon A., Gouze H., et al. Post-discharge persistent symptoms and health-related quality of life after hospitalization for COVID-19. J Infect. 2020;81:e4–e6.
- Lu Y., Li X., Geng D., Mei N., Wu P.-Y., Huang C.-C., et al. Cerebral micro-structural changes in COVID-19 patients - an MRI-based 3-month follow-up study. EClinicalMedicine. 2020;25:100484.
- Tabatabaei S.M.H., Rajebi H., Moghaddas F., Ghasemiadl M., Talari H. Chest CT in COVID-19 pneumonia: what are the findings in mid-term follow-up? Emerg Radiol. 2020;27:711–719.
- Fortini A., Torrigiani A., Sbaragli S., lo Forte A., Crociani A., Cecchini P., et al. COVID-19: persistence of symptoms and lung alterations after 3-6 months from hospital discharge. Infection. 2021;49:1007–1015.
- Sonnweber T., Sahanic S., Pizzini A., Luger A., Schwabl C., Sonnweber B., et al. Cardiopulmonary recovery after COVID-19: an observational prospective multicentre trial. Eur Respir J. 2021;57:2003481.
- Tawfik H.M., Shaaban H.M., Tawfik A.M. Post-covid-19 syndrome in egyptian healthcare staff: highlighting the carers sufferings. Electron J Gen Med. 2021;18
- Tleyjeh I.M., Saddik B., AlSwaidan N., AlAnazi A., Ramakrishnan R.K., Alhazmi D., et al. Prevalence and predictors of Post-Acute COVID-19 Syndrome (PACS) after hospital discharge: a cohort study with 4 months median follow-up. PloS One. 2021;16
- Stewart S., Newson L., Briggs T.A., Grammatopoulos D., Young L., Gill P. Long COVID risk - a signal to address sex hormones and women’s health. Lancet Regional Health Europe. 2021;11:100242.
- Lerner A.M., Robinson D.A., Yang L., Williams C.F., Newman L.M., Breen J.J., et al. Toward understanding COVID-19 recovery: National Institutes of Health workshop on postacute COVID-19. Ann Intern Med. 2021;174:999–1003.
- Rajan S., Khunti K., Alwan N., Steves C., Greenhalgh T., Macdermott N., et al. European Observatory on Health Systems and Policies; Copenhagen (Denmark): 2021. In the wake of the pandemic: Preparing for Long COVID [Internet] (Policy Brief, No. 39.) Available from:
- Steinman M.A., Auerbach A.D. Managing chronic disease in hospitalized patients. JAMA Int Med. 2013;173:1857–1858.
- Fofana N.K., Latif F., Sarfraz S., Bilal, Bashir M.F., Komal B. Fear and agony of the pandemic leading to stress and mental illness: an emerging crisis in the novel coronavirus (COVID-19) outbreak. Psych Res. 2020;291:113230.
- Al-Aly Z., Xie Y., Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. 2021;594:259–264.
- Daugherty S.E., Guo Y., Heath K., Dasmariñas M.C., Jubilo K.G., Samranvedhya J., et al. Risk of clinical sequelae after the acute phase of SARS-CoV-2 infection: retrospective cohort study. BMJ. 2021;373:n1098.
- Korompoki E., Gavriatopoulou M., Hicklen R.S., Ntanasis-Stathopoulos I., Kastritis E., Fotiou D., et al. Epidemiology and organ specific sequelae of post-acute COVID19: a narrative review. J Infect. 2021;83:1–16.
- Gavriatopoulou M., Korompoki E., Fotiou D., Ntanasis-Stathopoulos I., Psaltopoulou T., Kastritis E., et al. Organ-specific manifestations of COVID-19 infection. Clin Exp Med. 2020;20:493–506.
- Wang T., Du Z., Zhu F., Cao Z., An Y., Gao Y., et al. Comorbidities and multi-organ injuries in the treatment of COVID-19. Lancet. 2020;395:e52.
- Ramakrishnan R.K., Kashour T., Hamid Q., Halwani R., Tleyjeh I.M. Unraveling the mystery surrounding post-acute sequelae of COVID-19. Front Immunol. 2021;12:686029.
- Hayes L.D., Ingram J., Sculthorpe N.F. More than 100 persistent symptoms of SARS-CoV-2 (Long COVID): a scoping review. Front Med. 2021;8:2028.
- Groff D., Sun A., Ssentongo A.E., Ba D.M., Parsons N., Poudel G.R., et al. Short-term and long-term rates of postacute sequelae of SARS-CoV-2 infection: a systematic review. JAMA Netw Open. 2021;4
- Nasserie T., Hittle M., Goodman S.N. Assessment of the frequency and variety of persistent symptoms among patients with COVID-19: a systematic review. JAMA Netw Open. 2021;4
- Lopez-Leon S., Wegman-Ostrosky T., Perelman C., Sepulveda R., Rebolledo P.A., Cuapio A., et al. More than 50 long-term effects of COVID-19: a systematic review and meta-analysis. Sci Rep. 2021;11:16144.
- Michelen M., Manoharan L., Elkheir N., Cheng V., Dagens A., Hastie C., et al. Characterising long COVID: a living systematic review. BMJ Glob Health. 2021;6
- Iqbal F.M., Lam K., Sounderajah V., Clarke J.M., Ashrafian H., Darzi A. Characteristics and predictors of acute and chronic post-COVID syndrome: a systematic review and meta-analysis. EClinicalMedicine. 2021:36.
- Imrey P.B. Limitations of meta-analyses of studies with high heterogeneity. JAMA Netw Open. 2020;3:e1919325.
- Amin-Chowdhury Z., Ladhani S.N. Causation or confounding: why controls are critical for characterizing long COVID. Nat Med. 2021;27:1129–1130.
Source: PubMed